Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bill Facteau currently holds 23,729 shares of BioCardia, Inc. (BCDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bill Facteau has been a net neutral trader of BCDA stock. They have purchased $0 and sold $0 worth of shares.
Bill Facteau's most recent insider trade was on Jul 6, 2026, when they sold 8,000 shares at $0.00 per share.
Bill Facteau serves as Executive at BioCardia, Inc. (BCDA). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Bill Facteau holds the position of Executive at BioCardia, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Bill Facteau has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Bill Facteau was on Jul 6, 2026, when they purchased $0 worth of BCDA shares. This transaction involved 8,000 shares at N/A per share.
Bill Facteau currently owns 23,729 shares of BioCardia, Inc. (BCDA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bill Facteau's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bill Facteau has 2 Form 4 filings on record as an insider at BioCardia, Inc..
Set alerts for Bill Facteau and 40,000+ other insiders.